Publications by authors named "Mark Vater"

Claim this Profile
P
Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancer.
Vishnu Prasath, Hinda Boutrid, Robert Wesolowski, Mahmoud Abdel-Rasoul, Cynthia Timmers, Mark Vater

Breast Cancer Res Treat· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502.
Daniel G Stover, Roberto Salgado, Oleksander Savenkov, Karla Ballman, Erica L Mayer, Mark Vater

NPJ Breast Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review of epidemiological studies evaluating the association between exposure to man-made vitreous fibers and non-malignant respiratory diseases.
Natalie Suder Egnot, Hannah Allen, Rebecca Hazan, Mark F Vater, Hristina Denic-Roberts

Regul Toxicol Pharmacol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emissions associated with operations of four different additive manufacturing or 3D printing technologies.
Rachel E Zisook, Brooke D Simmons, Mark Vater, Angela Perez, Ellen P Donovan

J Occup Environ Hyg· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review and meta-analysis of epidemiological literature evaluating the association between exposure to man-made vitreous fibers and respiratory tract cancers.
Natalie Suder Egnot, Stacey M Benson, Mark F Vater, Rebecca Hazan, Opal Patel

Regul Toxicol Pharmacol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis